mannitol has been researched along with pulmicort in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 11 (45.83) | 29.6817 |
2010's | 12 (50.00) | 24.3611 |
2020's | 1 (4.17) | 2.80 |
Authors | Studies |
---|---|
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Anderson, SD; Brannan, JD; Chan, HK; Koskela, H | 1 |
Anderson, SD; Brannan, JD; Leuppi, JD | 1 |
Harjunen, P; Järvinen, K; Lankinen, T; Lehto, VP; Salonen, H | 1 |
Jhun, BH; Kim, DD; Kim, YS; Lee, CH; Lee, MK; Lee, SH; Roh, HJ; Yoo, JW | 1 |
Bolzen, N; Steckel, H | 1 |
Anderson, SD; Andersson, M; Bingisser, R; Brutsche, MH; Chan, HK; Greiff, L; Knoblauch, A; Leuppi, JD; Perruchoud, AP; Stolz, D; Surber, C; Tamm, M; Tandjung, R | 1 |
Björk, E; Ekelund, K; Johansson, F; Osth, K; Påhlstorp, C; Ulvenlund, S | 1 |
Cheruvu, NP; Kompella, UB | 1 |
Csepregi, A; Malfertheiner, P; Neumann, H; Sailer, M | 1 |
Caron, V; Descamps, M; Dudognon, E; Willart, JF | 1 |
Adi, H; Chan, HK; Heng, D; Kumon, M; Kwok, PC | 1 |
Chan, HK; Kwok, PC; Raper, JA; Tang, P; Tong, Z; Yang, R | 1 |
Chhajed, PN; Jochmann, A; Leuppi, JD; Maier, S; Miedinger, D; Schafroth Török, S; Scherr, A; Taegtmeyer, AB; Tamm, M | 1 |
Hindle, M; Longest, PW | 1 |
Halkola, T; Hirvonen, J; Järvinen, K; Kauppinen, EI; Laaksonen, T; Peltonen, L; Pessi, J; Rahikkala, A; Raula, J | 1 |
Rattanupatam, T; Srichana, T | 1 |
Chhajed, PN; Goll, A; Jochmann, A; Knöpfli, B; Leuppi, JD; Miedinger, D; Mueller, T; Sauter, S; Schafroth Török, S; Taegtmeyer, AB; Zellweger, LJ | 1 |
Buckton, G; Jones, MD | 1 |
Huang, Y; Huang, Z; Liao, Q; Pan, X; Peng, T; Wu, C; Wu, CY; Xu, J; Zhang, J; Zhang, X; Zhao, Z | 1 |
Foged, C; Leng, D; Thanki, K; Yang, M | 1 |
Birk, G; Hertel, N; Scherließ, R | 1 |
2 review(s) available for mannitol and pulmicort
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Bronchial provocation tests: the rationale for using inhaled mannitol as a test for airway hyperresponsiveness.
Topics: Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchodilator Agents; Budesonide; Forced Expiratory Volume; Humans; Mannitol; Saline Solution, Hypertonic | 2002 |
1 trial(s) available for mannitol and pulmicort
Article | Year |
---|---|
Response to add-on inhaled corticosteroids in COPD based on airway hyperresponsiveness to mannitol.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Bronchial Hyperreactivity; Budesonide; Diuretics, Osmotic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Male; Mannitol; Middle Aged; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Treatment Outcome | 2012 |
21 other study(ies) available for mannitol and pulmicort
Article | Year |
---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects.
Topics: Administration, Inhalation; Adult; Asthma; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchodilator Agents; Budesonide; Female; Forced Expiratory Volume; Humans; Male; Mannitol; Middle Aged; Pilot Projects; Time Factors | 2002 |
Effects of carriers and storage of formulation on the lung deposition of a hydrophobic and hydrophilic drug from a DPI.
Topics: Albuterol; Budesonide; Chemistry, Pharmaceutical; Drug Carriers; Drug Storage; Glucose; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Lung; Mannitol; Nebulizers and Vaporizers; Powders | 2003 |
Serially passaged human nasal epithelial cell monolayer for in vitro drug transport studies.
Topics: Biological Transport; Budesonide; Carbon Radioisotopes; Cells, Cultured; Electric Conductivity; Epithelial Cells; Humans; Mannitol; Microscopy, Electron; Nasal Mucosa; Pharmaceutical Preparations; Pharmacokinetics | 2003 |
Alternative sugars as potential carriers for dry powder inhalations.
Topics: Administration, Inhalation; Budesonide; Calorimetry, Differential Scanning; Chromatography, High Pressure Liquid; Drug Carriers; Glucose; Maltose; Mannitol; Microscopy, Electron, Scanning; Nebulizers and Vaporizers; Particle Size; Powders; Sorbitol; Sugar Alcohols; Sweetening Agents; Xylitol | 2004 |
Prediction of treatment-response to inhaled corticosteroids by mannitol-challenge test in COPD. A proof of concept.
Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Bronchial Provocation Tests; Bronchoconstrictor Agents; Bronchodilator Agents; Budesonide; Dose-Response Relationship, Drug; Female; Forced Expiratory Volume; Histamine; Humans; Male; Mannitol; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quality of Life; Spirometry; Treatment Outcome; Vital Capacity | 2005 |
Correlation between epithelial toxicity and surfactant structure as derived from the effects of polyethyleneoxide surfactants on caco-2 cell monolayers and pig nasal mucosa.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents, Non-Steroidal; Budesonide; Caco-2 Cells; Chemical Phenomena; Chemistry, Physical; Diffusion Chambers, Culture; Diuretics; Electric Impedance; Epithelial Cells; Humans; Light; Mannitol; Nasal Mucosa; Polyethylene Glycols; Propranolol; Scattering, Radiation; Structure-Activity Relationship; Surface Tension; Surface-Active Agents; Swine | 2005 |
Bovine and porcine transscleral solute transport: influence of lipophilicity and the Choroid-Bruch's layer.
Topics: Animals; Anti-Inflammatory Agents; Biological Transport; Bruch Membrane; Budesonide; Cattle; Celecoxib; Choroid; Diffusion Chambers, Culture; Fluorescein; Mannitol; Permeability; Pyrazoles; Rhodamines; Sclera; Sulfonamides; Swine; Water | 2006 |
Glatiramer acetate induced acute exacerbation of autoimmune hepatitis in a patient with multiple sclerosis.
Topics: Acute Disease; Adjuvants, Immunologic; Aged; Anti-Inflammatory Agents; Antibodies, Antinuclear; Budesonide; Drug Synergism; Glatiramer Acetate; Hepatitis, Autoimmune; Humans; Iatrogenic Disease; Interferon beta-1b; Interferon-beta; Liver; Male; Mannitol; Multiple Sclerosis; Mycophenolic Acid; Peptides; Treatment Outcome | 2007 |
Transformation of pharmaceutical compounds upon milling and comilling: the role of T(g).
Topics: Anti-Inflammatory Agents; Budesonide; Chemistry, Pharmaceutical; Crystallization; Drug Compounding; Drug Stability; Excipients; Lactose; Mannitol; Models, Chemical; Sorbitol; Technology, Pharmaceutical; Transition Temperature; Trehalose; Water | 2007 |
Can low-dose combination products for inhalation be formulated in single crystalline particles?
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Androstadienes; Budesonide; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Crystallization; Drug Combinations; Ethanolamines; Fluticasone-Salmeterol Drug Combination; Formoterol Fumarate; Humans; Mannitol; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Particle Size; Photoelectron Spectroscopy; Surface Properties; Transition Temperature; X-Ray Diffraction | 2010 |
Does the United States Pharmacopeia throat introduce de-agglomeration of carrier-free powder from inhalers?
Topics: Administration, Inhalation; Aerosols; Bronchodilator Agents; Budesonide; Dry Powder Inhalers; Equipment Design; Humans; Hydrodynamics; Mannitol; Particle Size; Powders; United States | 2012 |
Condensational growth of combination drug-excipient submicrometer particles for targeted high-efficiency pulmonary delivery: evaluation of formulation and delivery device.
Topics: Administration, Inhalation; Aerosols; Albuterol; Bronchodilator Agents; Budesonide; Chemistry, Pharmaceutical; Citric Acid; Drug Combinations; Drug Delivery Systems; Excipients; Humans; Hydrophobic and Hydrophilic Interactions; Lung; Mannitol; Metered Dose Inhalers; Models, Anatomic; Nanoparticles; Particle Size; Respiratory Mucosa; Sodium Chloride | 2012 |
Coated particle assemblies for the concomitant pulmonary administration of budesonide and salbutamol sulphate.
Topics: Administration, Inhalation; Aerosols; Albuterol; Bronchodilator Agents; Budesonide; Drug Combinations; Drug Compounding; Drug Delivery Systems; Excipients; Feasibility Studies; Glucocorticoids; Leucine; Mannitol; Nanoparticles; Nebulizers and Vaporizers; Particle Size; Solubility; Time Factors | 2013 |
Budesonide dry powder for inhalation: effects of leucine and mannitol on the efficiency of delivery.
Topics: Administration, Inhalation; Budesonide; Drug Carriers; Leucine; Mannitol; Particle Size; Powders; Spectroscopy, Fourier Transform Infrared | 2014 |
An open-label study examining the effect of pharmacological treatment on mannitol- and exercise-induced airway hyperresponsiveness in asthmatic children and adolescents with exercise-induced bronchoconstriction.
Topics: Acetates; Administration, Inhalation; Adolescent; Anti-Asthmatic Agents; Asthma, Exercise-Induced; Bronchial Provocation Tests; Bronchoconstrictor Agents; Bronchodilator Agents; Budesonide; Child; Cyclopropanes; Drug Administration Schedule; Exercise Test; Female; Forced Expiratory Volume; Humans; Male; Mannitol; Quinolines; Sulfides; Treatment Outcome; Young Adult | 2014 |
Comparison of the cohesion-adhesion balance approach to colloidal probe atomic force microscopy and the measurement of Hansen partial solubility parameters by inverse gas chromatography for the prediction of dry powder inhalation performance.
Topics: Adhesiveness; Administration, Inhalation; Albuterol; Beclomethasone; Budesonide; Chemistry, Pharmaceutical; Chromatography, Gas; Colloids; Drug Carriers; Dry Powder Inhalers; Erythritol; Lactose; Mannitol; Microscopy, Atomic Force; Particle Size; Pharmaceutical Preparations; Powders; Solubility; Terbutaline; Triamcinolone Acetonide | 2016 |
Nanoporous mannitol carrier prepared by non-organic solvent spray drying technique to enhance the aerosolization performance for dry powder inhalation.
Topics: Animals; Budesonide; Drug Carriers; Male; Mannitol; Nanoparticles; Particle Size; Porosity; Rats; Rats, Sprague-Dawley; Solvents | 2017 |
Formulating Inhalable Dry Powders Using Two-Fluid and Three-Fluid Nozzle Spray Drying.
Topics: Administration, Inhalation; Budesonide; Chemistry, Pharmaceutical; Desiccation; Dry Powder Inhalers; Excipients; Humans; Mannitol; Nanoparticles; Particle Size; Powders; Surface Properties; Technology, Pharmaceutical; Water | 2018 |
Particle engineered mannitol for carrier-based inhalation - A serious alternative?
Topics: Administration, Inhalation; Albuterol; Budesonide; Drug Carriers; Dry Powder Inhalers; Lactose; Mannitol; Mechanical Phenomena; Particle Size | 2020 |